Could a Head-Zapping device at home beat chronic fatigue?
NCT ID NCT05791812
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a gentle electrical brain stimulation device, used at home under remote supervision, can help reduce fatigue in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Twenty participants will use the device for 20 minutes each weekday over six weeks. The main goals are to see if the treatment is practical and if it improves fatigue and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
transcranial direct current stimulation (tDCS) device
What this could lead to
If it works, this could offer a convenient home-based treatment to reduce fatigue and improve quality of life for people with ME/CFS.
What could go wrong
This is a very small early study with only 20 participants and no placebo group, so results may not be reliable or generalizable. The treatment may also cause discomfort or skin irritation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Psychiatry and Psychotherapy, University of Regensburg
Regensburg, 93055, Germany